Phaos Technology Holdings (Cayman) (POAS) Inventory (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Inventory of $311655.0 for Q4 2025, up 34.38% on a QoQ basis from $231917.2 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Inventory (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Inventory history runs 2 years deep, the most recent figure standing at $311655.0 for Q4 2025.

Quarterly Inventory changed N/A year-over-year to $311655.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $311655.0 (changed N/A YoY) and the FY2025 annual result came in at $232129.6, up 66.67% from the prior year.
Inventory was $311655.0 for Q4 2025 at Phaos Technology Holdings (Cayman), up from $231917.2 in the prior quarter.
Across five years, Inventory topped out at $311655.0 in Q4 2025 and bottomed at $139277.8 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Abbott Laboratories	183.26 Bn	175.96 Bn	6.27 Bn	6.99 Bn
2	Stryker	128.79 Bn	125.92 Bn	3.81 Bn	5.42 Bn
3	Medtronic	108.56 Bn	99.34 Bn	6.41 Bn	5.95 Bn
4	Boston Scientific	68.31 Bn	66.86 Bn	3.61 Bn	3.12 Bn
5	Edwards Lifesciences	47.27 Bn	43.60 Bn	1.29 Bn	1.12 Bn
6	Dexcom	28.42 Bn	27.31 Bn	750.30 Mn	693.60 Mn
7	GE HealthCare Technologies	28.40 Bn	26.12 Bn	1.98 Bn	2.35 Bn
8	Smith & Nephew	26.95 Bn	26.37 Bn	-	2.12 Bn
9	Koninklijke Philips	25.52 Bn	22.40 Bn	2.07 Bn	3.64 Bn
10	Phaos Technology Holdings (Cayman)	6.17 Mn	6.12 Mn	-	311,655.00

Download Data